PrimeVax Immuno-Oncology Inc.
3 clinical trials · Sponsor
◉ Watch PrimeVax Immuno-Oncology Inc.
| Record | Firm | Date |
|---|---|---|
| Intratumoral Injection of PV-001-DV Plus DC in Patients With Melanoma (NCT03990493) | PrimeVax Immuno-Oncology Inc. | 2024-04-01 |
| Arm 1: Lysate Pulsed Dendritic Cells (PV-001-DC) in Patients With Melanoma (NCT03803397) | PrimeVax Immuno-Oncology Inc. | 2024-04-01 |
| Intratumoral Injection of Dengue Virus-1 #45AZ5 (PV-001-DV) in Patients With Melanoma (NCT03989895) | PrimeVax Immuno-Oncology Inc. | 2024-04-01 |
Track PrimeVax Immuno-Oncology Inc. automatically
Every clearance here is in the API, with alerts when new ones post.